Title :- Relation of MANKIND PHARMA with NIFTY50<\/p>\n
Author:- MANAV SANJEEV PAWAR, Roll. No:-44 , Div:- A, KBS.<\/p>\n
Mankind Pharma is one of India\u2019s leading pharmaceutical companies, known for its extensive portfolio of medicines across multiple therapeutic areas. Established in 1995, the company has expanded rapidly, focusing on affordable healthcare solutions. Mankind Pharma operates in both domestic and international markets, with a significant presence in over 30 countries. It offers pharmaceuticals, over-the-counter (OTC) products, and medical devices. The company\u2019s robust research and development capabilities, combined with its efficient supply chain, have positioned it as a key player in the pharmaceutical industry.<\/p>\n
Objective:<\/p>\n
To determine the Beta of Mankind Pharma and evaluate its significance in relation to the Nifty50 index.<\/p>\n
Data Collection:<\/p>\n
Mankind Pharma and Nifty50 data were collected for the period from 1-1-24 to 31-12-24. The data was processed to extract the Friday closing prices of Nifty50 (X) and Mankind Pharma (Y). A linear regression was performed using Mankind Pharma as the dependent variable and Nifty50 as the independent variable.<\/p>\n
\u00a0<\/p>\n
Data Analysis:<\/p>\n
\u00a0<\/p>\n
Regression Equation: Mankind Pharma = 1.842 + 1.457(Nifty50)<\/p>\n
Interpretation:<\/p>\n
The regression equation describes the relationship between Nifty50 and Mankind Pharma’s share price. The positive coefficient of 1.457 suggests that for every unit increase in Nifty50, Mankind Pharma’s share price is expected to increase by 1.457 units.<\/p>\n
With an R\u00b2 value of 0.12, approximately 12% of the variation in Mankind Pharma\u2019s share price can be explained by changes in Nifty50.<\/p>\n
The f-value is 5.82.<\/p>\n
The p-value of 0.038 is less than 0.05, indicating a statistically significant relationship between Nifty50 and Mankind Pharma\u2019s share price.<\/p>\n
Conclusion:<\/p>\n
Mankind Pharma\u2019s beta of 1.457 indicates that it is moderately more volatile than the market. This makes it a suitable option for investors seeking higher returns with some level of risk. Its significant positive correlation with Nifty50 suggests that the stock price tends to move in tandem with the overall market trends.<\/p>\n
Reference:<\/p>\n
David Perry, 2017. “2016 Status Report on Major Equipment Procurement,” SPP Research Papers, The School of Public Policy, University of Calgary, vol. 10(22), September.<\/p>\n
Karin Gourdon & Laurent Daniel & Takuya Adachi & Emilie Berger, 2023. “New Approaches to Shipbuilding Capacity Assessments,” OECD Science, Technology and Industry Policy Papers 140, OECD Publishing.<\/p>\n","protected":false},"excerpt":{"rendered":"
Title :- Relation of MANKIND PHARMA with NIFTY50 Author:- MANAV SANJEEV PAWAR, Roll. No:-44 , Div:- A, KBS. Mankind Pharma is one of India\u2019s leading pharmaceutical companies, known for its extensive portfolio of medicines across multiple therapeutic areas. Established in 1995, the company has expanded rapidly, focusing on affordable healthcare solutions. Mankind Pharma operates in… Continue reading MANKIND PHARMA<\/span><\/a><\/p>\n","protected":false},"author":139780,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-22849","post","type-post","status-publish","format-standard","hentry","category-uncategorized","entry"],"_links":{"self":[{"href":"http:\/\/www.sachdevajk.in\/index.php?rest_route=\/wp\/v2\/posts\/22849","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/www.sachdevajk.in\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.sachdevajk.in\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.sachdevajk.in\/index.php?rest_route=\/wp\/v2\/users\/139780"}],"replies":[{"embeddable":true,"href":"http:\/\/www.sachdevajk.in\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22849"}],"version-history":[{"count":1,"href":"http:\/\/www.sachdevajk.in\/index.php?rest_route=\/wp\/v2\/posts\/22849\/revisions"}],"predecessor-version":[{"id":22850,"href":"http:\/\/www.sachdevajk.in\/index.php?rest_route=\/wp\/v2\/posts\/22849\/revisions\/22850"}],"wp:attachment":[{"href":"http:\/\/www.sachdevajk.in\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22849"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.sachdevajk.in\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22849"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.sachdevajk.in\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22849"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}